Teclistamab in Relapsed or Refractory Multiple Myeloma

• A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma

  2025 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

  25

  citations
• Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study

  2025 The Lancet Haematology article Medicine Multiple Myeloma Research and Treatments Open access

  113

  citations
• A comparison of cryopreserved and noncryopreserved peripheral blood hematopoietic stem cells for autologous transplantation in multiple myeloma: a study from the chronic malignancies working party of the EBMT

  2025 Cytotherapy article Medicine Hematopoietic Stem Cell Transplantation Open access

  4

  citations
• Improving CD3 bispecific antibody therapy in solid tumors using combination strategies

  2025 Frontiers in Oncology article Medicine Monoclonal and Polyclonal Antibodies Research Open access

  5

  citations
• Opportunities and limitations of B cell depletion approaches in SLE

  2025 Nature Reviews Rheumatology review Medicine Systemic Lupus Erythematosus Research Open access

  81

  citations
• Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis

  2025 Blood Advances article Medicine CAR-T cell therapy research Open access

  16

  citations
• Allogeneic Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma—A Retrospective Multicenter Analysis

  2024 European Journal Of Haematology article Medicine Multiple Myeloma Research and Treatments Open access

  1

  citations
• Retrospective study on pomalidomide‐ PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma

  2024 European Journal Of Haematology article Medicine Multiple Myeloma Research and Treatments Open access

  5

  citations
• Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab

  2024 Clinical Lymphoma Myeloma & Leukemia article Medicine Multiple Myeloma Research and Treatments Open access

  49

  citations
• Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

  2024 Haematologica article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access

  5

  citations
• Real-world analysis of teclistamab in 123 RRMM patients from Germany

  2024 Leukemia article Medicine Multiple Myeloma Research and Treatments Open access

  119

  citations

11 results